PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-47.05%
Negative revenue growth while Insurance - Life median is -6.49%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-47.05%
Negative gross profit growth while Insurance - Life median is -6.49%. Seth Klarman would suspect poor product pricing or inefficient production.
203.84%
EBIT growth exceeding 1.5x Insurance - Life median of 1.16%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
203.84%
Operating income growth exceeding 1.5x Insurance - Life median of 0.90%. Joel Greenblatt would see if unique processes drive exceptional profitability.
175.82%
Net income growth of 175.82% while Insurance - Life median is zero. Walter Schloss might see potential if moderate gains can keep rising.
175.81%
EPS growth of 175.81% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
175.82%
Positive diluted EPS growth while Insurance - Life median is negative. Peter Lynch might see a real advantage in how this firm manages share count or drives net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.08%
Negative OCF growth while Insurance - Life median is -33.27%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-25.08%
Negative FCF growth while Insurance - Life median is -36.28%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
4.67%
10Y CAGR of 4.67% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
42.44%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 17.25%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
-45.96%
Negative 3Y CAGR while Insurance - Life median is -4.66%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
484.16%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 34.22% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
51.08%
5Y OCF/share growth 1.25-1.5x Insurance - Life median. Mohnish Pabrai would see if consistent operational improvements enable better cash yields.
86.25%
3Y OCF/share growth of 86.25% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
53.66%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 32.03% over a decade. Joel Greenblatt might see a standout compounder of earnings.
141.42%
5Y net income/share CAGR > 1.5x Insurance - Life median of 46.12%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
87.66%
3Y net income/share CAGR of 87.66% while Insurance - Life median is zero. Walter Schloss might see a small advantage that can be scaled further.
71.41%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 29.48% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
68.93%
5Y equity/share CAGR > 1.5x Insurance - Life median of 35.83%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
10.70%
3Y equity/share CAGR near Insurance - Life median. Charlie Munger notes it as typical short-term equity expansion in the sector.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.09%
AR growth of 2.09% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
1.41%
We expand assets while Insurance - Life is negative. Peter Lynch sees a possible advantage if expansions align with profitable markets or a recovering cycle.
4.57%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
0.07%
Debt growth far outpacing Insurance - Life median. Jim Chanos suspects over-leveraging or deteriorating financial discipline.
No Data
No Data available this quarter, please select a different quarter.
-5.75%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.